Fubon Ice Factset Taiwan Core Semiconductor Index ETF(03076.HK) fell 0.62% to HKD 17.770
Newtimespace News, as of 15:00 on May 13, Fubon Ice Factset Taiwan Core Semiconductor Index ETF(03076.HK) was quoted at HKD 17.770, down 0.62%. The ETF opened at HKD 17.880, with a high of HKD 18.100 and a low of HKD 17.600. The latest NAV per unit is HKD 18.097, with a premium rate of -1.20%. The asset size is approximately HKD 54.2847 million.
Fubon Ice Factset Taiwan Core Semiconductor Index ETF(03076.HK) is a passive exchange-traded fund (ETF) issued and managed by Fubon Asset Management (Hong Kong) Limited. Its primary investment objective is to provide, before fees and expenses, investment returns that closely track the performance of the NYSE FactSet Taiwan Core Semiconductor 10% Capped OTC Index (Net Total Return). The index is compiled and published by the globally renowned financial data and index provider ICE Data Indices, LLC (with related business integrated following its merger with FTSE Russell). The index methodology is highly representative of the industry, specifically focusing on semiconductor companies listed on the Taiwan Stock Exchange that possess core competitive advantages. In its stock selection logic, the index not only considers a company's market capitalization and liquidity but also extensively covers key segments of the semiconductor industry chain. This includes global-leading wafer foundry manufacturing, advanced integrated circuit design (fabless model), professional packaging and testing services, as well as key semiconductor production equipment and materials suppliers.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Henlius (02696.HK): HLX48 (EGFR/c-MET Dual-target ADC) Secures Australian Approval for Phase I Clinical Trial
- Henlius (02696.HK): HLX97 (KAT6A/B Inhibitor) Completes First Patient Dosing in Phase I Clinical Trial for Advanced Solid Tumors
- INNOSCIENCE(02577.HK) closed 19.26% higher, the Hang Seng Semiconductors Sector saw divergent trends
- E Fund (HK) HSI ESG Enhanced Index ETF (03039.HK) Fell 0.05%, with the Closing Price at HKD 3.818
- iShares Hang Seng TECH ETF (03067.HK) rose 0.56% to close at HKD 10.720